{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:31:42Z","timestamp":1777984302682,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Capital\u2018s Funds for Health Improvement and Research","award":["2024-2-2177"],"award-info":[{"award-number":["2024-2-2177"]}]},{"name":"Beijing Municipal Administration of Hospitals Incubating Program","award":["PX2022072"],"award-info":[{"award-number":["PX2022072"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04686-9","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T04:03:21Z","timestamp":1770869001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological features of hepatobiliary cells in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid"],"prefix":"10.1186","volume":"26","author":[{"given":"Kun","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiamin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"10457","key":"4686_CR1","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0140-6736(24)01303-5","volume":"404","author":"A Tanaka","year":"2024","unstructured":"Tanaka A, Ma X, Takahashi A, Vierling JM. Primary biliary cholangitis. Lancet. 2024;404(10457):1053\u201366.","journal-title":"Lancet"},{"key":"4686_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.37349\/ei.2024.00163","volume":"4","author":"VI Reshetnyak","year":"2024","unstructured":"Reshetnyak VI, Maev IV. Mechanism of formation and significance of antimitochondrial autoantibodies in the pathogenesis of primary biliary cholangitis. Explor Immunol. 2024;4:624\u201339.","journal-title":"Explor Immunol"},{"issue":"9","key":"4686_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/17474124.2023.2242771","volume":"17","author":"A De Floreani","year":"2023","unstructured":"Floreani A, Gabbia D, De Martin S. Primary biliary cholangitis: primary autoimmune disease or primary secretory defect. Expert Rev Gastroenterol Hepatol. 2023;17(9):863\u201370.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7","key":"4686_CR4","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.14309\/ajg.0000000000000557","volume":"115","author":"CF Murillo Perez","year":"2020","unstructured":"Murillo Perez CF, Harms MH, Lindor KD, van Buuren HR, Hirschfield GM, Corpechot C, GLOBAL PBC Study Group, et al. Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase. Am J Gastroenterol. 2020;115(7):1066\u201374.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"4686_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12876-025-04138-w","volume":"25","author":"T Koky","year":"2025","unstructured":"Koky T, Drazilova S, Janicko M, Toporcerova D, Gazda J, Jarcuska P. Early assessment of treatment response in primary biliary cholangitis: key to timely management. BMC Gastroenterol. 2025;25(1):571.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"4686_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12072-022-10431-7","volume":"17","author":"C Yang","year":"2023","unstructured":"Yang C, Guo G, Li B, Zheng L, Sun R, Wang X, et al. Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion. Hepatol Int. 2023;17(1):237\u201348.","journal-title":"Hepatol Int"},{"issue":"6","key":"4686_CR7","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/hep.25614","volume":"55","author":"P Sancho-Bru","year":"2012","unstructured":"Sancho-Bru P, Altamirano J, Rodrigo-Torres D, Coll M, Mill\u00e1n C, Jos\u00e9 Lozano J, et al. Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology. 2012;55(6):1931\u201341.","journal-title":"Hepatology"},{"issue":"1","key":"4686_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12876-022-02538-w","volume":"22","author":"HL Liu","year":"2022","unstructured":"Liu HL, Yang AY, Xiong QF, Zhong YD, Liu DX, Huang P, et al. Aberrant cytokeratin 7 expression by hepatocytes can predict the ductopenia grade in primary biliary cholangitis. BMC Gastroenterol. 2022;22(1):443.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"4686_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","volume":"69","author":"KD Lindor","year":"2019","unstructured":"Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M, Primary Biliary C. 2018 practice guidance from the American association for the study of liver diseases. Hepatology. 2019;69(1):394\u2013419.","journal-title":"Hepatology"},{"issue":"6","key":"4686_CR10","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","volume":"55","author":"C Corpechot","year":"2011","unstructured":"Corpechot C, Chazouill\u00e8res O, Poupon R. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol. 2011;55(6):1361\u20137.","journal-title":"J Hepatol"},{"issue":"3","key":"4686_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.32074\/1591-951X-245","volume":"113","author":"S Sarcognato","year":"2021","unstructured":"Sarcognato S, Sacchi D, Grillo F, Cazzagon N, Fabris L, Cadamuro M, et al. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis. Pathologica. 2021;113(3):170\u201384.","journal-title":"Pathologica"},{"issue":"3","key":"4686_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","volume":"60","author":"Y Nakanuma","year":"2010","unstructured":"Nakanuma Y, Zen Y, Harada K, Sasaki M, Nonomura A, Uehara T, et al. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: interobserver agreement. Pathol Int. 2010;60(3):167\u201374.","journal-title":"Pathol Int"},{"issue":"13","key":"4686_CR13","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.3748\/wjg.v20.i13.3597","volume":"20","author":"M Kobayashi","year":"2014","unstructured":"Kobayashi M, Kakuda Y, Harada K, Sato Y, Sasaki M, Ikeda H, et al. Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis. World J Gastroenterol. 2014;20(13):3597\u2013608.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4686_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13000-021-01102-6","volume":"16","author":"N Sj\u00f6blom","year":"2021","unstructured":"Sj\u00f6blom N, Boyd S, Manninen A, Knuuttila A, Blom S, F\u00e4rkkil\u00e4 M, et al. Chronic cholestasis detection by a novel tool: automated analysis of cytokeratin 7-stained liver specimens. Diagn Pathol. 2021;16(1):41.","journal-title":"Diagn Pathol"},{"issue":"6","key":"4686_CR15","doi-asserted-by":"publisher","first-page":"e0179","DOI":"10.1097\/HC9.0000000000000179","volume":"7","author":"J Trivella","year":"2023","unstructured":"Trivella J, John BV, Levy C. Primary biliary cholangitis: Epidemiology, prognosis, and treatment. Hepatol Commun. 2023;7(6):e0179.","journal-title":"Hepatol Commun"},{"issue":"7","key":"4686_CR16","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/apt.16023","volume":"52","author":"KK Leung","year":"2020","unstructured":"Leung KK, Deeb M, Hirschfield GM. Review article: pathophysiology and management of primary biliary cholangitis. Aliment Pharmacol Ther. 2020;52(7):1150\u201364.","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"4686_CR17","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.cgh.2020.06.062","volume":"19","author":"AJ Montano-Loza","year":"2021","unstructured":"Montano-Loza AJ, Corpechot C. Definition and management of patients with primary biliary cholangitis and an incomplete response to therapy. Clin Gastroenterol Hepatol. 2021;19(11):2241\u2013e22511.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"4686_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/liv.14688","volume":"41","author":"D Haldar","year":"2021","unstructured":"Haldar D, Janmohamed A, Plant T, Davidson M, Norman H, Russell E, et al. Antibodies to gp210 and Understanding risk in patients with primary biliary cholangitis. Liver Int. 2021;41(3):535\u201344.","journal-title":"Liver Int"},{"issue":"8","key":"4686_CR19","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.dld.2021.10.011","volume":"54","author":"Q Chen","year":"2022","unstructured":"Chen Q, Zhong R, Dong K, Wang Y, Kui Y, Ma B, et al. The prognostic value of antibodies to gp210 among patients with primary biliary cholangitis in Northeast China. Dig Liver Dis. 2022;54(8):1094\u2013100.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"4686_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1053\/bega.2000.0106","volume":"14","author":"J Ludwig","year":"2000","unstructured":"Ludwig J. The pathology of primary biliary cirrhosis and autoimmune cholangitis. Baillieres Best Pract Res Clin Gastroenterol. 2000;14(4):601\u201313.","journal-title":"Baillieres Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"4686_CR21","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696\u20139.","journal-title":"J Hepatol"},{"issue":"10","key":"4686_CR22","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/apt.15533","volume":"50","author":"CF Murillo Perez","year":"2019","unstructured":"Murillo Perez CF, Hirschfield GM, Corpechot C, Floreani A, Mayo MJ, van der Meer A, et al. GLOBAL PBC study Group. Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response. Aliment Pharmacol Ther. 2019;50(10):1127\u201336.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"4686_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/hepr.13593","volume":"51","author":"T Namisaki","year":"2021","unstructured":"Namisaki T, Fujinaga Y, Moriya K, Yoshiji H. The association of histological progression with biochemical response to ursodeoxycholic acid in primary biliary cholangitis. Hepatol Res. 2021;51(1):31\u20138.","journal-title":"Hepatol Res"},{"issue":"9","key":"4686_CR24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S2468-1253(18)30163-8","volume":"3","author":"M Carbone","year":"2018","unstructured":"Carbone M, Nardi A, Flack S, Carpino G, Varvaropoulou N, Gavrila C, et al. Italian PBC study group and the UK\u2013PBC Consortium. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA response score. Lancet Gastroenterol Hepatol. 2018;3(9):626\u201334.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"18","key":"4686_CR25","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3390\/cells13181580","volume":"13","author":"S Fiorucci","year":"2024","unstructured":"Fiorucci S, Urbani G, Di Giorgio C, Biagioli M, Distrutti E. Current landscape and evolving therapies for primary biliary cholangitis. Cells. 2024;13(18):1580.","journal-title":"Cells"},{"issue":"11","key":"4686_CR26","doi-asserted-by":"publisher","first-page":"100556","DOI":"10.1016\/j.jhepr.2022.100556","volume":"4","author":"D Overi","year":"2022","unstructured":"Overi D, Carpino G, Cristoferi L, Onori P, Kennedy L, Francis H, Zucchini N, Rigamonti C, Vigan\u00f2 M, Floreani A, D\u2019Amato D, Gerussi A, Venere R, Alpini G, Glaser S, Alvaro D, Invernizzi P, Gaudio E, Cardinale V, Carbone M. Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitis. JHEP Rep. 2022;4(11):100556.","journal-title":"JHEP Rep"},{"issue":"1","key":"4686_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/hepr.13584","volume":"51","author":"K Kawata","year":"2021","unstructured":"Kawata K, Joshita S, Shimoda S, Yamashita Y, Yamashita M, Kitsugi K, et al. The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis. Hepatol Res. 2021;51(1):80\u20139.","journal-title":"Hepatol Res"},{"key":"4686_CR28","doi-asserted-by":"publisher","unstructured":"Sakellariou S, Michaelides C, Voulgaris T, Vlachogiannakos J, Manesis E, Tiniakos DG, et al. Keratin 7 expression in hepatic cholestatic diseases. Virchows Arch. 2021;479(4):815\u201324 https:\/\/doi.org\/10.1007\/s00428-021-03152-z. Epub 2021 Jul 27. Erratum in: Virchows Arch. 2021;479(4):825\u2013826.","DOI":"10.1007\/s00428-021-03152-z"},{"issue":"3","key":"4686_CR29","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jhep.2023.04.013","volume":"79","author":"B Aguilar-Bravo","year":"2023","unstructured":"Aguilar-Bravo B, Ari\u00f1o S, Blaya D, Pose E, de la Martinez Garc\u00eda RA, Latasa MU, et al. Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming. J Hepatol. 2023;79(3):728\u201340.","journal-title":"J Hepatol"},{"issue":"1","key":"4686_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/hep.31679","volume":"74","author":"K Jung","year":"2021","unstructured":"Jung K, Kim M, So J, Lee SH, Ko S, Shin D. Farnesoid X receptor activation impairs liver progenitor Cell-Mediated liver regeneration via the PTEN-PI3K-AKT-mTOR axis in zebrafish. Hepatology. 2021;74(1):397\u2013410.","journal-title":"Hepatology"},{"issue":"8","key":"4686_CR31","doi-asserted-by":"publisher","first-page":"e0483","DOI":"10.1097\/HC9.0000000000000483","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang S, Link F, Munker S, Wang W, Feng R, Liebe R, et al. Retinoic acid generates a beneficial microenvironment for liver progenitor cell activation in acute liver failure. Hepatol Commun. 2024;8(8):e0483.","journal-title":"Hepatol Commun"},{"issue":"2","key":"4686_CR32","doi-asserted-by":"publisher","first-page":"e100074","DOI":"10.1136\/egastro-2024-100074","volume":"2","author":"T Li","year":"2024","unstructured":"Li T, Hasan MN, Gu L. Bile acids regulation of cellular stress responses in liver physiology and diseases. eGastroenterology. 2024;2(2):e100074.","journal-title":"eGastroenterology"},{"issue":"1","key":"4686_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41467-021-27758-8","volume":"13","author":"H Hu","year":"2022","unstructured":"Hu H, Shao W, Liu Q, Liu N, Wang Q, Xu J, et al. Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion. Nat Commun. 2022;13(1):252.","journal-title":"Nat Commun"},{"issue":"5","key":"4686_CR34","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/hep.29717","volume":"67","author":"CF Murillo Perez","year":"2018","unstructured":"Murillo Perez CF, Goet JC, Lammers WJ, Gulamhusein A, van Buuren HR, Ponsioen CY, GLOBAL PBC Study Group, et al. Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history. Hepatology. 2018;67(5):1920\u201330.","journal-title":"Hepatology"},{"issue":"1","key":"4686_CR35","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.5493\/wjem.v15.i1.101771","volume":"15","author":"VI Reshetnyak","year":"2025","unstructured":"Reshetnyak VI, Maev IV. Bile acid therapy for primary biliary cholangitis: pathogenetic validation. World J Exp Med. 2025;15(1):101771.","journal-title":"World J Exp Med"},{"issue":"37","key":"4686_CR36","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.3748\/wjg.v29.i37.5292","volume":"29","author":"VI Reshetnyak","year":"2023","unstructured":"Reshetnyak VI, Maev IV. New insights into the pathogenesis of primary biliary cholangitis asymptomatic stage. World J Gastroenterol. 2023;29(37):5292\u2013304.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4686_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MOG.0000000000000703","volume":"37","author":"J Prieto","year":"2021","unstructured":"Prieto J, Banales JM, Medina JF. Primary biliary cholangitis: pathogenic mechanisms. Curr Opin Gastroenterol. 2021;37(2):91\u20138.","journal-title":"Curr Opin Gastroenterol"},{"key":"4686_CR38","doi-asserted-by":"publisher","first-page":"1327973","DOI":"10.3389\/fmed.2024.1327973","volume":"11","author":"HN Pham","year":"2024","unstructured":"Pham HN, Pham L, Sato K. Deconvolution analysis identified altered hepatic cell landscape in primary sclerosing cholangitis and primary biliary cholangitis. Front Med (Lausanne). 2024;11:1327973.","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"4686_CR39","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/17474124.2025.2537192","volume":"19","author":"A Floreani","year":"2025","unstructured":"Floreani A, Gabbia D, De Martin S. Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitis. Expert Rev Gastroenterol Hepatol. 2025;19(8):891\u2013902.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"5","key":"4686_CR40","first-page":"489","volume":"32","author":"R Agrawal","year":"2019","unstructured":"Agrawal R, Majeed M, Attar BM, Omar YA, Mbachi C, Wang Y, et al. Effectiveness of bezafibrate and ursodeoxycholic acid in patients with primary biliary cholangitis: a meta-analysis of randomized controlled trials. Ann Gastroenterol. 2019;32(5):489\u201397.","journal-title":"Ann Gastroenterol"},{"issue":"9","key":"4686_CR41","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S2468-1253(18)30163-8","volume":"3","author":"M Carbone","year":"2018","unstructured":"Carbone M, Nardi A, Flack S, Carpino G, Varvaropoulou N, Gavrila C, Italian PBC Study Group and the UK-PBC Consortium, et al. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA response score. Lancet Gastroenterol Hepatol. 2018;3(9):626\u201334.","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04686-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04686-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04686-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:27:23Z","timestamp":1773829643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04686-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4686"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04686-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6763526\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving patients were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study protocol was approved by the Ethics Committee of Beijing Ditan Hospital, capital medical University (NO. DTEC-KY2024-023-01). Informed consent was obtained from patients in the study. A written informed consent from participants were obtained by physicians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}